Abiopharma

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Via Transportation (VIA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Kuehn Law Encourages Investors of Grocery Outlet Holding Corp. to Contact Law Firm

Vertical Aerospace Announces Financing Commitments of Approximately $100 Million to Advance Certification and Commercialisation

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

ESS Reschedules Second Quarter 2026 Financial Results Conference Call to Tuesday, August 11, 2026 at 5:00 p.m. Eastern Time

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion

Duos Technologies Group Sets Second Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma